Gavin Clark-Gartner

Stock Analyst at Evercore ISI Group

(0)
# 4726
Out of 5,441 analysts
31
Total ratings
Success rate
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
MIRM Mirum Pharmaceutical...
Maintains: Outperform
77 89
65.86 35.14% 3 Aug 8, 2025
JSPR Jasper Therapeutics
Maintains: Outperform
50 20
2.62 663.36% 3 Jul 8, 2025
PRQR ProQR Therapeutics
Initiates Coverage On: Outperform
5
1.89 164.55% 1 Apr 29, 2025
ABBV AbbVie
Maintains: Outperform
204 205
198.62 3.21% 3 Apr 28, 2025
MNMD Mind Medicine
Initiates Coverage On: Outperform
23
9.98 130.46% 1 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
15 6
1.32 354.55% 2 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
675 706
638.76 10.53% 4 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
179 170
17.95 847.08% 9 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
4.69 326.44% 1 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
201 206
137.58 49.73% 1 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
22
1.64 1241.46% 1 Oct 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 10
2.42 313.22% 1 May 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 60
21.27 182.09% 1 Oct 5, 2022